医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ASP Japan G.K. Informs the Opening of Yamato Factory – Toward Further Kaizen

2023年07月04日 AM09:00
このエントリーをはてなブックマークに追加


 

TOKYO

On July 1, 2023, ASP Japan, G.K. opened and began operations at its Yamato Factory in Yamato-city, Kanagawa Prefecture.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230703514230/en/

ASP Japan, G.K. Yamato Factory (Photo: Business Wire)

ASP Japan, G.K. Yamato Factory (Photo: Business Wire)

https://www.asp.co.jp/activities/yamato-factory

The Yamato Factory is positioned as the manufacturing center for STERRAD™ in Japan, and is held to strict evaluation and shipping standards to ensure delivery of the device to the medical community.

By bringing the above capabilities to the domestic manufacturer, we expect to shorten the manufacturing lead time for STERRAD™ and improve the initial defect rate and other factors.

At ASP Japan, G.K., our customers’ success inspires our innovation.

About ASP Japan, G.K.

As a leading company in the fields of cleaning and disinfection and sterilization, ASP Japan, G.K. continues to create an environment that provides safe and secure medical care through innovative products and services.

To protect patients at their most critical moments™ – all ASP employees involved in this mission never stop moving forward and always challenge the status quo to solve our customers’ problems.

ASP has a history of innovation in the fields of low-temperature sterilization and high-level disinfection. We developed the world’s first hydrogen peroxide gas plasma sterilization system, STERRAD™, a low-temperature sterilizer with improved safety and shorter sterilization time, which is earthquake-proof because it operates only on electricity. As a market leader in the low-temperature sterilizer market, we provide innovative products and services.

In the field of high-level disinfection, we have developed DisOPA™, which offers improved safety, shorter disinfection time, and ease of use. As a brand leader in the field of high-level disinfection, together with the Endoclens™ soft endoscope cleaning and disinfection device, DisOPA™ contributes to improving the quality and efficiency of soft endoscope reprocessing.

Product Name: STERRAD™ 100NX
Product Name: STERRAD NX™
Product Name: STERRAD™100S
Product Name: ENDOCLENS™ Neo
Product Name: ENDOCLENS™ -S
Product Name: ENDOCLENS™ -D
Product Name: DisOPA™ Solution 0.55%

View source version on businesswire.com: https://www.businesswire.com/news/home/20230703514230/en/

CONTACT

ASP Japan G.K., Head Office

+813-6712-1011

同じカテゴリーの記事 

  • European Medicines Agency Accepts Deciphera’s Marketing Authorization Application for Vimseltinib for Treatment of Patients with Tenosynovial Giant Cell Tumor (TGCT)
  • JCR Pharmaceuticals Highlights Innovative Gene Therapy Research at the 7th International Forum of Lysosomal Disorders
  • Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance
  • ベイジーン、アーロン・ローゼンバーグ氏を最高財務責任者に任命
  • ICH and CDISC Collaborate to Support the Maintenance and Governance Process for ICH M11 Controlled Terminology